drugset / Trial / NCT00003063

Biological Therapy With Combination Chemotherapy in Patients With Colorectal Cancer

NCT00003063

Phase 3 Unknown 1050 enrolled European Institute of Oncology
RandomizedTreatment

Summary

RATIONALE: Biological therapies use different ways to stimulate the immune system and stop cancer cells from growing. Combining chemotherapy with biological therapy may kill more tumor cells. PURPOSE: Randomized phase III trial to compare the effectiveness of treatment using levamisole with treatment using interferon alfa and combination chemotherapy consisting of fluorouracil and leucovorin in patients with stage II or stage III colorectal cancer.

Timeline

Start
1991-11
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Levamisole Small molecule Oral
Subject interferon alfa Protein / enzyme biologic Subcutaneous
Background Leucovorin Small molecule Intravenous
Background fluorouracil Small molecule Intravenous

Indications